World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
41642
World Ranking
9155
National Ranking
4724

Overview

Cesar A. Moran is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research contributions span mainly the field of Medicine, with a focus on Pulmonary and Respiratory Medicine, Oncology, Neurology, Surgery, and Epidemiology.

Their work covers several main topics, including Myasthenia Gravis and Thymoma, Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Medical Imaging and Pathology Studies, Pituitary Gland Disorders and Treatments, Metastasis and Carcinoma Case Studies, and Neuroblastoma Research and Treatments.

Moran has published extensively in multiple scientific journals. Frequent publication venues include:

  • Pathology - Research and Practice
  • Advances in Anatomic Pathology
  • Seminars in Diagnostic Pathology
  • International Journal of Surgical Pathology
  • The American Journal of Surgical Pathology

The scientist has also contributed to book publications, notably a 2023 title published by Frontiers Media named "Thymoma and Thymic Carcinoma: Diagnostic Imaging, Pathological Assessment, and Treatment Options."

Some recent papers involving or co-authored by Moran include:

  • Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology (2021), Journal of the National Comprehensive Cancer Network
  • Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer (2020), Nature Cancer
  • Comprehensive T cell repertoire characterization of non-small cell lung cancer (2020), Nature Communications
  • Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy (2020), Clinical Lung Cancer
  • CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance (2023), Cancer Cell

Frequent co-authors who have collaborated with Moran include:

  • Ignacio I. Wistuba
  • Annikka Weissferdt
  • John V. Heymach
  • Neda Kalhor
  • Carmen Behrens

Best Publications

  • The Immune Landscape of Cancer

    Vésteinn Thorsson;David L Gibbs;Scott D Brown;Denise Wolf

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Comprehensive Characterization of Cancer Driver Genes and Mutations.

    Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing

    Jianjun Zhang;Junya Fujimoto;Jianhua Zhang;David C. Wedge

  • Pathogenic Germline Variants in 10,389 Adult Cancers

    Kuan-Lin Huang;R Jay Mashl;Yige Wu;Deborah I Ritter

  • Nrf2 and Keap1 Abnormalities in Non–Small Cell Lung Carcinoma and Association with Clinicopathologic Features

    Luisa M. Solis;Carmen Behrens;Wenli Dong;Milind Suraokar

  • Solitary fibrous tumors of soft tissue. A clinicopathologic and immunohistochemical study of 12 cases.

    Saul Suster;Antonio G. Nascimento;Markku Miettinen;Joshua Z. Sickel

  • Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas

    Franz X. Schaub;Varsha Dhankani;Ashton C. Berger;Mihir Trivedi

  • Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set

    David S. Klimstra;Irvin R. Modlin;N. Volkan Adsay;Runjan Chetty

  • Neuroendocrine carcinomas (carcinoid tumor) of the thymus. A clinicopathologic analysis of 80 cases.

    Cesar A. Moran;Saul Suster

  • The Masaoka-Koga stage classification for thymic malignancies: clarification and definition of terms.

    Frank C. Detterbeck;Andrew G. Nicholson;Kazuya Kondo;Paul Van Schil

  • [18F] fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer

    Ryohei Sasaki;Ritsuko Komaki;Homer Macapinlac;Jeremy Erasmus

  • Expression of bcl-2 Oncoprotein in Benign and Malignant Spindle Cell Tumors of Soft Tissue, Skin, Serosal Surfaces, and Gastrointestinal Tract

    Saul Suster;Cyril Fisher;Cesar A. Moran

  • Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

    Joshua D. Campbell;Joshua D. Campbell;Joshua D. Campbell;Christina Yau;Christina Yau;Reanne Bowlby;Yuexin Liu

  • Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience.

    Arlene O. Siefker-Radtke;Colin P. Dinney;Neil A. Abrahams;Cesar Moran

  • Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer.

    C. Allison Stewart;Yuanxin Xi;Santhosh Sivajothi

  • NCCN guidelines® insights: Small cell lung cancer, version 2.2018 featured updates to the NCCN guidelines

    Gregory P. Kalemkerian;Billy W. Loo;Wallace Akerley;Albert Attia

  • The spectrum of histologic growth patterns in benign and malignant fibrous tumors of the pleura

    Cesar A. Moran;Saul Suster;Saul Suster;Michael N. Koss;Michael N. Koss

  • Management of primary pulmonary artery sarcomas.

    Shanda H. Blackmon;David C Rice;Arlene M Correa;Reza John Mehran

  • Liposarcoma of the anterior mediastinum and thymus. A clinicopathologic study of 28 cases.

    David S. Klimstra;Cesar A. Moran;Giorgio Perino;Michael N. Koss

Frequent Co-Authors

Saul Suster
Saul Suster Medical College of Wisconsin
Ignacio I. Wistuba
Ignacio I. Wistuba The University of Texas MD Anderson Cancer Center
Carmen Behrens
Carmen Behrens The University of Texas MD Anderson Cancer Center
John V. Heymach
John V. Heymach The University of Texas MD Anderson Cancer Center
Stephen G. Swisher
Stephen G. Swisher The University of Texas MD Anderson Cancer Center
Humam Kadara
Humam Kadara The University of Texas MD Anderson Cancer Center
David C. Rice
David C. Rice The University of Texas MD Anderson Cancer Center
J. Jack Lee
J. Jack Lee The University of Texas MD Anderson Cancer Center
Michael Koss
Michael Koss ETH Zurich
Don L. Gibbons
Don L. Gibbons The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

In addition to traditional routes, many students explore online medical degree options and alternative careers in healthcare. One popular pathway is pursuing rn to bsn online programs, which offer registered nurses an affordable and flexible way to advance their education while continuing to work. These online programs allow you to earn a bachelor's degree in nursing from anywhere, helping you qualify for broader roles.

For those entering the nursing profession with a non-nursing background, msn direct entry programs online provide an accelerated pathway to a Master of Science in Nursing. These programs are designed for career changers looking to quickly transition into advanced nursing roles.

If acceptance rates are a concern, there are nursing programs with high acceptance rates available online. These schools make entering the field more accessible without compromising on the quality of education.

Beyond nursing, fields like medical billing and coding also present viable healthcare careers. For those concerned about costs, consider schools that offer financial aid for medical billing and coding programs, providing affordable options to obtain your certification and enter the workforce quickly.

Best Scientists Citing Cesar A. Moran

Trending Scientists

Recently Published Articles